These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18586492)

  • 1. Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase.
    Ye B; Bauman J; Chen M; Davey D; Khim SK; King B; Kirkland T; Kochanny M; Liang A; Lentz D; May K; Mendoza L; Phillips G; Selchau V; Schlyer S; Tseng JL; Wei RG; Ye H; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3891-4. PubMed ID: 18586492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel and potent aryl diamines as leukotriene A4 hydrolase inhibitors.
    Khim SK; Bauman J; Evans J; Freeman B; King B; Kirkland T; Kochanny M; Lentz D; Liang A; Mendoza L; Phillips G; Tseng JL; Wei RG; Ye H; Yu L; Parkinson J; Guilford WJ
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3895-8. PubMed ID: 18590959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of non-urea inhibitors of soluble epoxide hydrolase.
    Pecic S; Deng SX; Morisseau C; Hammock BD; Landry DW
    Bioorg Med Chem Lett; 2012 Jan; 22(1):601-5. PubMed ID: 22079754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of N-mercaptoacylproline and N-mercaptoacylthiazolidine-4-carboxylic acid derivatives as leukotriene A4 hydrolase inhibitors.
    Enomoto H; Morikawa Y; Miyake Y; Tsuji F; Mizuchi M; Suhara H; Fujimura K; Horiuchi M; Ban M
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4529-32. PubMed ID: 18674901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unsymmetrical non-adamantyl N,N'-diaryl urea and amide inhibitors of soluble expoxide hydrolase.
    Anandan SK; Webb HK; Do ZN; Gless RD
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4259-63. PubMed ID: 19520575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives.
    Jiang X; Zhou L; Wei D; Meng H; Liu Y; Lai L
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6549-52. PubMed ID: 18952425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel leukotriene A4 hydrolase inhibitors based on piperidine and piperazine scaffolds.
    Sandanayaka V; Mamat B; Bhagat N; Bedell L; Halldorsdottir G; Sigthorsdottir H; Andrésson T; Kiselyov A; Gurney M; Singh J
    Bioorg Med Chem Lett; 2010 May; 20(9):2851-4. PubMed ID: 20371179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A(4) hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Liang CD; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2002 Dec; 12(23):3383-6. PubMed ID: 12419366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Grice CA; Tays KL; Savall BM; Wei J; Butler CR; Axe FU; Bembenek SD; Fourie AM; Dunford PJ; Lundeen K; Coles F; Xue X; Riley JP; Williams KN; Karlsson L; Edwards JP
    J Med Chem; 2008 Jul; 51(14):4150-69. PubMed ID: 18588282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of dual target inhibitors against cyclooxygenases and leukotriene A4 hydrolyase.
    Chen Z; Wu Y; Liu Y; Yang S; Chen Y; Lai L
    J Med Chem; 2011 May; 54(10):3650-60. PubMed ID: 21542630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of glutamic acid analogs as potent inhibitors of leukotriene A4 hydrolase.
    Kirkland TA; Adler M; Bauman JG; Chen M; Haeggström JZ; King B; Kochanny MJ; Liang AM; Mendoza L; Phillips GB; Thunnissen M; Trinh L; Whitlow M; Ye B; Ye H; Parkinson J; Guilford WJ
    Bioorg Med Chem; 2008 May; 16(9):4963-83. PubMed ID: 18394906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase.
    Jones PD; Tsai HJ; Do ZN; Morisseau C; Hammock BD
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5212-6. PubMed ID: 16870439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities.
    Kasagami T; Kim IH; Tsai HJ; Nishi K; Hammock BD; Morisseau C
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1784-9. PubMed ID: 19216074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.
    Appiah-Kubi P; Soliman M
    Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of imidazopyridines and purines as potent inhibitors of leukotriene A4 hydrolase.
    Penning TD; Chandrakumar NS; Desai BN; Djuric SW; Gasiecki AF; Malecha JW; Miyashiro JM; Russell MA; Askonas LJ; Gierse JK; Harding EI; Highkin MK; Kachur JF; Kim SH; Villani-Price D; Pyla EY; Ghoreishi-Haack NS; Smith WG
    Bioorg Med Chem Lett; 2003 Mar; 13(6):1137-9. PubMed ID: 12643929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A strategy of employing aminoheterocycles as amide mimics to identify novel, potent and bioavailable soluble epoxide hydrolase inhibitors.
    Shen HC; Ding FX; Deng Q; Xu S; Tong X; Zhang X; Chen Y; Zhou G; Pai LY; Alonso-Galicia M; Roy S; Zhang B; Tata JR; Berger JP; Colletti SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5716-21. PubMed ID: 19700315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of SC-57461A (3-[methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic acid HCl), a potent and selective inhibitor of leukotriene A(4) hydrolase II: in vivo studies.
    Kachur JF; Askonas LJ; Villani-Price D; Ghoreishi-Haack N; Won-Kim S; Liang CD; Russell MA; Smith WG
    J Pharmacol Exp Ther; 2002 Feb; 300(2):583-7. PubMed ID: 11805220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of N-mercaptoacylcysteine derivatives as leukotriene A4 hydrolase inhibitors.
    Enomoto H; Morikawa Y; Miyake Y; Tsuji F; Mizuchi M; Suhara H; Fujimura K; Horiuchi M; Ban M
    Bioorg Med Chem Lett; 2009 Jan; 19(2):442-6. PubMed ID: 19042128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure activity relationship of human microsomal epoxide hydrolase inhibition by amide and acid analogues of valproic acid.
    Spiegelstein O; Kroetz DL; Levy RH; Yagen B; Hurst SI; Levi M; Haj-Yehia A; Bialer M
    Pharm Res; 2000 Feb; 17(2):216-21. PubMed ID: 10751038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alpha lipoic acid on leukotriene A
    Torres MJ; Fierro A; Pessoa-Mahana CD; Romero-Parra J; Cabrera G; Faúndez M
    Eur J Pharmacol; 2017 Mar; 799():41-47. PubMed ID: 28132911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.